Assessment of Liquid Microbead Arrays for the Screening of Newborns for Spinal Muscular Atrophy
Author(s) -
Robert E. Pyatt,
David Mihal,
Thomas W. Prior
Publication year - 2007
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2007.092312
Subject(s) - microbead (research) , spinal muscular atrophy , smn1 , exon , microbiology and biotechnology , medicine , atrophy , pathology , biology , gene , genetics
Spinal muscular atrophy is a common neurodegenerative disorder that has recently been considered for inclusion in the next generation of newborn screening regimens. We sought to validate liquid microbead arrays for the identification of affected individuals by direct DNA analysis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom